Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer [Phase 1]
This Phase 1 trial evaluates CBM588 in combination with nivolumab and ipilimumab for advanced or stage IV renal cell carcinoma; the study ha…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses [NA]
A UNC Lineberger Comprehensive Cancer Center-sponsored trial evaluating Genomic Risk Assessment and Decisional Evaluation for Small Renal Ma…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of PF-06952229 in adults with advanced solid tumors was terminated. Results were posted on 2024-06-26.
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma [Phase 1]
A Phase 1 study evaluating abemaciclib in combination with sunitinib for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic [Phase 2]
Phase 2 study of pembrolizumab in patients with rare, unresectable or metastatic solid tumors; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Novel Prognostic Markers in Renal Cancer
This clinical trial update summarizes findings from a completed study investigating novel prognostic markers in renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) [Phase 1]
This document describes a Phase 1 dose-escalation trial of PT2385 in patients with advanced clear cell renal cell carcinoma (renal cell carc…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of ADCT-301 in Patients With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial update for ADCT-301 (camidanlumab tesirine) in selected advanced solid tumors; the study has been terminated and results have …
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer [NA]
A trial evaluating stereotactic body radiation therapy for metastatic or recurrent renal cell carcinoma was terminated; results were posted …
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of immunotherapy combinations across multiple advanced cancers and has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau [Phase 2]
A Phase 2 trial assessing contrast-enhanced ultrasound for screening kidney cancer in patients with Von Hippel-Lindau disease has completed,…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 multi-center trial of ESK981 in combination with nivolumab for metastatic renal cell carcinoma was terminated, and results were po…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with stereotactic ablative radiotherapy for metastatic colorectal cancer, non-…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.
Pfizer-sponsored real-world study assesses patterns of care and outcomes in AfME patients with metastatic renal cell carcinoma treated with …
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 [Phase 1]
A first-in-human Phase 1 trial of BMC128 in combination therapy evaluating a single dose level, across multiple cancers; status is active bu…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
This clinical trial update reports the completion of studies examining biomarkers of angiogenesis in renal cell carcinoma and neuroendocrine…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: VEGF Imaging in Renal Cell Carcinoma
A clinical trial sponsored by University Medical Center Groningen evaluating VEGF imaging in renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma
A completed clinical trial evaluating VEGF imaging before and during everolimus treatment for metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy [Phase 3]
This Phase 3 clinical trial update reports results for nivolumab in localized renal cell carcinoma patients undergoing nephrectomy, with the…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy [Phase 3]
Phase 3 trial update evaluating nivolumab in patients with localized kidney cancer undergoing nephrectomy; status ACTIVE_NOT_RECRUITING with…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of DSP-7888 Dosing Emulsion in combination with immune checkpoint inhibitors in adults with advanced solid tumors was termin…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating sintilimab in combination with Inlyta for fumarate hydratase-deficient renal cell carcinoma is currently active but…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating microwave ablation with MRI-guided SBRT boost for renal cell carcinoma; study terminated with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab [Phase 2]
Phase 2 trial update evaluating intermittent therapy in metastatic renal cell carcinoma patients treated with ipilimumab and nivolumab.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for a study evaluating safety, efficacy, and pharmacokinetics in participants with advanced solid tumors, including re…